Intellia Therapeutics Inc buy Wells Fargo & Company
Start price
10.01.25
/
50%
€10.22
Target price
10.01.26
€58.40
Performance (%)
-11.94%
End price
11.01.26
€9.00
Summary
This prediction ended on 11.01.26 with a price of €9.00. The price of Intellia Therapeutics Inc has decreased during the runtime of the prediction. Compared to the start price this resulted in a performance of -11.94%. Wells_Fargo___Compan has a follow-up prediction for Intellia Therapeutics Inc where he still thinks Intellia Therapeutics Inc is a Buy. Wells_Fargo___Compan has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| Intellia Therapeutics Inc | 8.566% | 8.566% | 11.686% |
| iShares Core DAX® | -0.383% | 1.093% | 11.642% |
| iShares Nasdaq 100 | -0.411% | -1.973% | 7.273% |
| iShares Nikkei 225® | 1.838% | 10.261% | 31.381% |
| iShares S&P 500 | -0.712% | 0.445% | 4.295% |
Comments by Wells_Fargo___Compan for this prediction
In the thread Intellia Therapeutics Inc diskutieren
Intellia Therapeutics, Inc. (NASDAQ: NTLA) had its price target lowered by analysts at Wells Fargo & Company from $70.00 to $60.00. They now have an "overweight" rating on the stock.
Ratings data for NTLA provided by MarketBeat
In the thread Trading Intellia Therapeutics Inc
Die von Wells_Fargo___Compan gewählte maximale Laufzeit wurde überschritten
Current prediction by Wells_Fargo___Compan for Intellia Therapeutics Inc
Intellia Therapeutics Inc
Start price
Target price
Perf. (%)
€9.50
28.02.25
28.02.25
€48.09
28.02.26
28.02.26
22.74%
27.02.26
27.02.26
Stopped prediction by Wells_Fargo___Compan for Intellia Therapeutics Inc
Intellia Therapeutics Inc
Start price
Target price
Perf. (%)
€9.49
08.08.25
08.08.25
-
08.08.26
08.08.26
22.89%
27.02.26
27.02.26
Intellia Therapeutics Inc
Start price
Target price
Perf. (%)
€13.35
18.11.24
18.11.24
€66.07
18.11.25
18.11.25
-46.02%
19.11.25
19.11.25